Diabetes Monitoring Devices Market

The Diabetes Monitoring Devices Market is valued at USD 12.3 Bn in 2026 and is projected to reach USD 17.77 Bn,  growing at a CAGR of 5% by 2033.

Diabetes monitoring devices are used to help monitor the patient's health, which helps them manage their condition through healthy habits and insulin therapy.

Recent advances in the field have included the development of continuous glucose monitors that allow for continuous measurement of glucose levels via a subcutaneous interstitial fluid sensor inserted just below the skin. These systems provide improved accuracy over traditional blood glucose meters because they measure the amount of sugar present in interstitial fluid (the fluid between cells). However, they are not as accurate as the blood glucose meters, and currently, they do not make insulin dosing decisions for people with diabetes.

Changing lifestyle and aging population are the key risk factors

There has been an increase in the demand for diabetes monitoring devices due to increased rates of obesity, which is one of the leading risk factors for type 2 diabetes. According to the Diseases and Conditions department of the U.S. National Institutes of Health, more than 9% of American adults have diabetes while another 16% have pre-diabetes (a condition in which a person's blood glucose level is higher than normal but not high enough to be diagnosed as Type 2 diabetes). Diabetes is more prevalent among Americans who are middle aged or older, less educated, have certain racial/ethnic groups, have low income or live-in certain regions of the country. In 2010 alone, medical costs associated with diabetes were calculated at about $116 billion for hospital care, $58 billion for physician services and nearly $3 million for prescription drugs.

Demand for diabetes monitoring devices has increased alongside these statistics due to the risk factors that come with diabetes, including increased age and obesity. Type 2 diabetes is most commonly diagnosed in adults over the age of 40 that are overweight or obese and who have a family history of the condition.

Global market to offer huge potential for diabetes monitoring devices

The global diabetes monitoring devices market has grown progressively over the last decade due to demand for these tools among patients looking to manage their blood glucose levels in order to prevent complications associated with diabetes such as blindness, renal failure and amputation of lower extremities (source: National Diabetes Information Clearinghouse). Commercialized technologies of these devices, the growing number of diabetes patients and increasing awareness about self-monitoring blood glucose (SMBG) are likely to drive the market over the forecast period.

Insulin pumps are among the most commonly used device in today's market. However, with healthcare practitioners advising their patients against the use of insulin pumps due to its ineffectiveness when it comes to overnight use, demand for non-insulin pump based sensors that can be worn continuously for 24 hours is expected to increase over the forecast period. The continuous glucose monitoring systems market is expected to register a significant growth in coming years, driven by the introduction of products such as Dexcom G4 and Abbott's Freestyle Navigator Pro. Continuous glucose monitoring system helps in optimizing glycemic control through regulation of insulin dosage and frequency based on overall glucose values measured from patient's blood samples.

In addition to diabetes, people with other conditions or diseases can also benefit from these devices when it comes to managing their condition better at home reducing the need for frequent office visits. Regulatory authorities have approved some of these technologies for use in medical facilities and clinics. For example, blood glucose meters are approved for hospital use while the FDA has cleared the Dexcom G4 Platinum for in-clinic use.

Introduction of advanced diabetes monitoring devices to spur the demand

Poor control of blood sugar levels can lead to a number of complications such as blindness, renal failure and amputation of lower extremities. In addition, elevated blood pressure caused by poor control of high blood sugars can cause heart attacks and strokes. The increasing prevalence rates of diabetes has led to innovations in the global market for diabetic monitoring devices such as latest technology offering no pain blood glucose monitoring systems that do not require finger pricking or painful lancet device penetration into the skin (source: National Diabetes Information Clearinghouse). Such innovative products will further aid people with Type I and II diabetes in reducing their frequency of office visits and improving their overall quality of life.

Demand for these technologies is expected to increase over the forecast period. The increasing number of diabetes patients and rise in awareness about managing blood glucose levels at home will drive these disruptive technologies across the globe. Moreover, with healthcare facilities encouraging self-management and prescribing of these devices for monitoring blood sugar, demand for such tools is expected to increase further (source: Diabetes Forecast). For instance, clinics and hospitals across the globe specifically recommend patients to purchase home use monitor for their product compliance with hospital guidance on appropriate treatment protocols.

Competitive landscape: diabetes monitoring devices market to witness intense competition  

Almost all modern models of monitoring devices have been designed not only for use at home but also within the workplace where individuals can check these numbers on a time clock or even during breaks to manage their glucose levels better while they are away from their homes. Many of these devices also have manuals that explain what each number means to help those who are not accustomed to dealing with their health care needs regularly. They can be purchased online from companies such as Accu-Chek, Bayer, Genteel and One Touch for prices ranging from $20–100 depending upon the model being purchased.

Key Players 

• Abbott Laboratories
• Dexcom, Inc.
• Medtronic plc
• Roche Diabetes Care
• Ascensia Diabetes Care
• Becton, Dickinson and Company (BD)
• LifeScan (OneTouch)
• Ypsomed AG
• Sanofi
• Siemens Healthineers
• ARKRAY, Inc.
• Senseonics Holdings, Inc.
• Tandem Diabetes Care, Inc.
• Insulet Corporation
• Nova Biomedical

 Global Diabetes Monitoring Devices Market Segmnetation

Type

• BGM Devices
  • Self-Monitoring Devices
  • Continuous Glucose Monitoring Devices
• Insulin Delivery Devices
  • Pumps
  • Pens
  • Syringes
  • Jet Injectors

Distribution Channel

• Hospital pharmacies
• Retail Pharmacies
• Diabetes Clinics/Centers
• Online Pharmacies
• Others

End-use

• Hospitals
• Diagnostic Centers
• Homecare

By Region

• North America
• Europe
• Asia Pacific
• Latin America
• Middle East and Africa